NATCO Pharma 配当と自社株買い
配当金 基準チェック /46
NATCO Pharmaは配当を支払う会社で、現在の利回りは0.42%ですが、利益によって十分にカバーされています。次の支払い日は 13th December, 2024で、権利落ち日は27th November, 2024 。
主要情報
0.4%
配当利回り
0%
バイバック利回り
| 総株主利回り | 0.4% |
| 将来の配当利回り | 0.5% |
| 配当成長 | 4.4% |
| 次回配当支払日 | 13 Dec 24 |
| 配当落ち日 | 27 Nov 24 |
| 一株当たり配当金 | ₹5.750 |
| 配当性向 | 5% |
最近の配当と自社株買いの更新
NATCO Pharma (NSE:NATCOPHARM) Has Announced A Dividend Of ₹1.50
Nov 18
NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21Recent updates
NATCO Pharma (NSE:NATCOPHARM) Has Announced A Dividend Of ₹1.50
Nov 18Earnings Beat: NATCO Pharma Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 15We Ran A Stock Scan For Earnings Growth And NATCO Pharma (NSE:NATCOPHARM) Passed With Ease
Oct 13NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market
Aug 13If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity
Jul 15NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02配当金の支払いについて
決済の安定と成長
配当データの取得
安定した配当: NATCOPHARMの配当金支払いは、過去10年間 変動性 が高かった。
増加する配当: NATCOPHARMの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| NATCO Pharma 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (NATCOPHARM) | 0.4% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.2% |
| 業界平均 (Pharmaceuticals) | 0.7% |
| アナリスト予想 (NATCOPHARM) (最長3年) | 0.5% |
注目すべき配当: NATCOPHARMの配当金 ( 0.42% ) はIndian市場の配当金支払者の下位 25% ( 0.25% ) よりも高くなっています。
高配当: NATCOPHARMの配当金 ( 0.42% ) はIndian市場の配当金支払者の上位 25% ( 1.15% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: NATCOPHARMの配当性向は低く ( 5.3% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: NATCOPHARMは 現金配当性向 ( 8% ) が低いため、配当金の支払いはキャッシュフローによって完全にカバーされています。